Mike DiMeo joined the Vibalogics executive board as Chief Financial Officer (CFO) in 2021.
Mike has 15 years of experience in finance for companies in the life sciences sector. He joined Vibalogics from Exosome Diagnostics, a subsidiary of Bio-Techne, where he served as Director of Finance. Prior to that, Mike worked at Thermo Fisher Scientific, where he served first as Finance Director of the Chromatography & Mass Spectrometry Division, before becoming Vice President of Finance for the Life Sciences Group.
At Vibalogics, Mike plays a key role in supporting and driving Vibalogics’ expansion strategy in North America. He works to devise the finance and investment strategy to deliver strong, sustainable growth in the North America region as well as the wider world.
Mike has a MBA in Strategic Management from the D’Amore-McKim School of Business at Northeastern University and a Bachelor’s degree in Biology from Northeastern University.